Briacell Therapeutics Corp. logo

Briacell Therapeutics Corp. (BCTX) Q3 2024 Annual Earnings

BCTX·Reported July 30, 2024·Before market open

Diluted EPS came in at $-0.73.

Diluted EPS
$-0.73
SEC

SEC Filings

Earnings release8-K not filed yet
Annual report10-K · 0001493152-24-042743

Financial Snapshot

Trailing eight quarters through Q3 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q3 2024 Earnings FAQ

Common questions about Briacell Therapeutics Corp.'s Q3 2024 earnings report.

Briacell Therapeutics Corp. (BCTX) reported Q3 2024 earnings on July 30, 2024 before market open.

Briacell Therapeutics Corp. reported diluted EPS of $-0.73 for Q3 2024.

You can read the 10-K periodic report (0001493152-24-042743) directly on SEC EDGAR. The filing index links above go to sec.gov.